A novel semi-automated in situ hybridisation protocol for microRNA detection in paraffin embedded tissue sections

Journal of Clinical Pathology

Volumn 68, Issue 8, 2015, Pages 661-664

  Gualeni, Ambra Vittoria ^a   Volpi, Chiara Costanza ^a   Carbone, Antonino ^b   Gloghini, Annunziata ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMINOBENZIDINE; FORMALDEHYDE; MICRORNA; MICRORNA 155; PARAFFIN; PEROXIDASE; 3,3'-DIAMINOBENZIDENE; BENZENE DERIVATIVE; DIGOXIGENIN; FIXATIVE;

ARTICLE; AUTOMATION; CANCER TISSUE; CELLULAR DISTRIBUTION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; TISSUE SECTION; BIOPSY; DIAGNOSTIC USE; EVALUATION STUDY; GENETICS; LABORATORY AUTOMATION; NEOPLASM; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; TISSUE FIXATION; TUMOR CELL LINE; WORKFLOW;

AUTOMATION, LABORATORY; BENZENE DERIVATIVES; BIOPSY; CELL LINE, TUMOR; DIGOXIGENIN; FIXATIVES; FORMALDEHYDE; HUMANS; IN SITU HYBRIDIZATION; MICRORNAS; NEOPLASMS; PARAFFIN EMBEDDING; PEROXIDASE; PREDICTIVE VALUE OF TESTS; TISSUE FIXATION; WORKFLOW;

EID: 84937972975     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2015-203005     Document Type: Article

References (22)

1. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120: 15-20.
2. Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009;19: 92-105.
3. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18: 997-1006.
4. Hanke M, Hoefig K, Merz H, et al. A robust methodology to study urine microRNA as tumor marker: MicroRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 2010;28: 655-61.
5. Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010;127: 118-26.
6. Xie Y, Todd NW, Liu Z, et al. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 2010;67: 170-6.
7. Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol 2014;9: 287-314.
8. Nana-Sinkam SP, Croce CM. Clinical applications for microRNAs in cancer. Clin Pharmacol Ther 2013;93: 98-104.
9. Jørgensen S, Baker A, Møller S, et al. Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 2010;52: 375-81.
10. Gandrillon O, Solari F, Legrand C, et al. A rapid and convenient method to prepare DIG-labelled RNA probes for use in non-radioactive in situ hybridization. Mol Cell Probes 1996;10: 51-5.
11. Shi Z, Johnson JJ, Stack MS. Fluorescence in situ hybridization for microRNA detection in archived oral cancer tissues. J Oncol 2012;2012: 903581.
12. Darnell DK, Stanislaw S, Kaur S, et al. Whole mount in situ hybridization detection of mRNAs using short LNA containing DNA oligonucleotide probes. RNA 2010;16: 632-7.
13. Kluiver J, Poppema S, de Jong D, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005;207: 243-9.
14. Eis PS, Tam W, Sun L, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci 2005;102: 3627-32.
15. Rask L, Balslev E, Jørgensen S, et al. High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS 2011;119: 663-73.
16. Schee K, Boye K, Abrahamsen TW, et al. Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC Cancer 2012;12: 505.
17. Lakomy R, Sana J, Hankeova S, et al. Mir-195, miR-196b, miR-181c, miR-21 expression levels and O-6 methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci 2011;102: 2186-90.
18. Tan LP, Wang M, Robertus JL, et al. miRNA profiling of B-cell subsets: Specific miRNA profile for germinal centre B cells with variation between centroblasts and centrocytes. Lab Invest 2009;89: 708-16.
19. Watanabe A, Tagawa H, Yamashita J, et al. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 2011;25: 1324-34.
20. Carbone A, Gualeni AV, Volpi CC, et al. MicroRNA detection in tumor tissue by in situ hybridization. WCRJ 2014;1: E407.
21. Silahtaroglu AN, Nolting D, Dyrskjot L, et al. Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nat Protoc 2007;2: 2520-8.
22. Singh U, Keirstead N, Wolujczyk A, et al. General principles and methods for routine automated microRNA in situ hybridization and double labelling with immunohistochemistry. Biotech Histochem 2014;89: 259-66.